FEATURE: Fund Managers Tell Genomics Cos. to Batten Down the Hatches | GenomeWeb

NEW YORK, April 16 - The bearish winds on Wall street have blown shut the doors to the capital markets, which means genomics companies will have to make do -- or perish -- with the funds they have raised so far, buy-side fund managers said Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.